4.5 Article

Health-related quality of life and family function following pediatric liver transplantation

Journal

LIVER TRANSPLANTATION
Volume 14, Issue 4, Pages 460-468

Publisher

WILEY
DOI: 10.1002/lt.21352

Keywords

-

Funding

  1. AHRQ HHS [5 R03 HS013270] Funding Source: Medline

Ask authors/readers for more resources

This multicenter study compared health-related quality of life (HRQOL) and family function of pediatric liver transplant recipients to those of healthy children to determine if this population differed from a healthy population and to distinguish which pretransplant and posttransplant factors impact HRQOL and family function. HRQOL data from 102 patients achieving 2-year survival were collected with the Infant Toddler Quality of Life Instrument or the Child Health Questionnaire Parent Form 50 parent surveys. Family functioning was assessed with the Family Assessment Device (FAD) completed by each participant's family members. Demographic and clinical information were retrieved from the Studies of Pediatric Liver Transplant database. Recipients 5 years of age and older scored lower than a normative sample in physical health (P < 0.001), general health (P < 0.001), parental emotional impact (P < 0.001), and disruption of family activities (P < 0.001). Younger children, 2 to 5 years of age, scored lower than controls in global health (P = 0.004) and general health perceptions (P < 0.001) but did not differ in subscales measuring physical and psychosocial outcomes. Univariate analysis among the subscales identified demographic but not clinical variables as significant predictors of HRQOL. Mean scores of FAD scales were below published thresholds indicating healthy family functioning. As reported in previous studies, parents of older recipients reported higher levels of stress, although their level of family function appears normal. Significant associations were also observed between FAD scores and demographic variables, suggesting that further investigation of the impact of race, parental marital status, and socio-economic status on the patient rehabilitation process is needed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pediatrics

Sarcopenia prevalence in pediatric intestinal transplant recipients: Implications on post-transplant outcomes

Vikram K. Raghu, Rita Sico, Jeffrey A. Rudolph, George Mazariegos, Judy Squires, James E. Squires

Summary: This study provides the first report of sarcopenia in pediatric intestinal transplantation, finding a high prevalence without association with worse outcomes. Sarcopenic patients may have improved graft survival, with potential underlying mechanisms for further exploration.

PEDIATRIC TRANSPLANTATION (2022)

Editorial Material Gastroenterology & Hepatology

Sixty years of functional clotting assays in pediatric liver transplantation

Kyle A. Soltys, George V. Mazariegos

LIVER TRANSPLANTATION (2022)

Article Gastroenterology & Hepatology

Factors associated with improved patient and graft survival beyond 1 year in pediatric liver transplantation

James E. Squires, Jacob Bilhartz, Kyle Soltys, Einar Hafberg, George Mazariegos, Nitika A. Gupta, Ravinder Anand, Sarah G. Anderson, Tamir Miloh

Summary: With advances in surgical techniques and medical management, children who receive a liver transplantation can expect remarkable outcomes early after transplant. However, long-term graft loss and mortality rates have not improved. Despite changes in patient selection and no significant improvement in perioperative complications, significant improvements in graft loss and a trend towards improvement in mortality were observed in a more contemporary cohort of children receiving a liver transplantation.

LIVER TRANSPLANTATION (2022)

Article Gastroenterology & Hepatology

Next-generation pathology detection of T cell-antigen-presenting cell immune synapses in human liver allografts

Michelle A. Wood-Trageser, Drew Lesniak, Alessandro Gambella, Kayla Golnoski, Sandy Feng, John Bucuvalas, Alberto Sanchez-Fueyo, A. Jake Demetris

Summary: The detection of immune pairs (iPAIRs) by next-generation pathology (NGP) can predict the failure of immunosuppression weaning in pediatric liver transplant recipients. The presence and importance of immune synapse formation in liver allografts have been confirmed, and it can be used to adjust immunosuppressive therapy and provide more information through gene analysis.

HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Health Care Transition for Adolescents and Young Adults With Pediatric-Onset Liver Disease and Transplantation: A Position Paper by the North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition

Jennifer Vittorio, Beverly Kosmach-Park, Lindsay Y. King, Ryan Fischer, Emily M. Fredericks, Vicky L. Ng, Amrita Narang, Sara Rasmussen, John Bucuvalas

Summary: Advancements in medical therapies and liver transplantation have allowed more pediatric patients to reach adulthood, but the transition from pediatric to adult hepatology and transplant services poses increased risks. Health care transition (HCT) is the process of shifting from child/family-centered care to adult/patient-centered care. This paper presents joint consensus guidelines to facilitate a structured, multidisciplinary approach to transition planning and calls for the implementation of an HCT program across pediatric and adult hepatology and transplant centers.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2023)

Editorial Material Gastroenterology & Hepatology

Waitlist mortality in pediatric liver transplantation: The goal is zero

George V. Mazariegos, Kyle A. Soltys, Emily R. Perito

LIVER TRANSPLANTATION (2023)

Editorial Material Pediatrics

Technical variant liver grafts in pediatric transplantation: Call to action

George V. Mazariegos, Rakesh Sindhi, Armando Ganoza, Kyle Soltys

PEDIATRIC TRANSPLANTATION (2023)

Review Pediatrics

Operational tolerance after intestine re-transplantation in childhood and immunological correlates. Case report and review

Lisa Remaley, Chethan Ashokkumar, Kyle A. Soltys, George Vincent Mazariegos, Geoffrey James Bond, Ajai Khanna, Armando Ganoza, Miguel Reyes-Mugica, Adriana Zeevi, Rakesh Sindhi

Summary: This study reports a third case of operational tolerance after intestine transplantation, confirming donor-specific hyporesponsiveness in the recipient. The three cases of operational tolerance share common characteristics of a relatively large donor antigenic load transmitted during transplantation and donor-specific hyporesponsiveness. Enhanced donor-induced apoptosis of recipient T-cells may be a mechanistic link between antigenic load and donor-specific hyporesponsiveness.

PEDIATRIC TRANSPLANTATION (2023)

Article Surgery

Distinct association between chronic Epstein-Barr virus infection and T cell compartments from pediatric heart kidney, and liver transplant recipients

Masaki Yamada, Camila Macedo, Kevin Louis, Tiange Shi, Douglas Landsittel, Christina Nguyen, Masayoshi Shinjoh, Marian G. Michaels, Brian Feingold, George V. Mazariegos, Michael Green, Diana Metes

Summary: Chronic Epstein-Barr virus (EBV) infection is a significant problem after pediatric organ transplantation, especially in heart transplant recipients with high viral load. This study analyzed the immune characteristics of CD8(+)/CD4(+) T cells in pediatric heart, kidney, and liver transplant recipients, and identified distinct phenotypic and transcriptomic profiles in heart HVL carriers. The results suggest different incidences of EBV complications and provide insights for risk stratification and clinical management in different types of transplant recipients.

AMERICAN JOURNAL OF TRANSPLANTATION (2023)

Article Gastroenterology & Hepatology

Center use of technical variant grafts varies widely and impacts pediatric liver transplant waitlist and recipient outcomes in the United States

George V. Mazariegos, Emily R. Perito, James E. Squires, Kyle A. Soltys, Adam D. Griesemer, Sarah A. Taylor, Eric Pahl

Summary: This retrospective analysis of OPTN data from 2004 to 2020 evaluated the impact of technical variant grafts (TVGs) on waitlist and transplant outcomes for pediatric liver transplant candidates. The study found that higher utilization of TVGs, particularly from deceased donors or living donors, was significantly associated with lower waitlist mortality. Therefore, increasing the utilization of TVGs is critical to decrease waitlist mortality.

LIVER TRANSPLANTATION (2023)

Review Pediatrics

Liver transplantation for alpha 1 antitrypsin deficiency (A1ATD) using a heterozygous donor: Outcomes and review of the literature

Vikrant Sood, Eliza J. Lee, Vikram Raghu, Miguel Reyes-Mugica, Claudia M. Salgado, James Squires, George Mazariegos

Summary: This study presents a unique case of using A1ATD heterozygote donors for pediatric patients with A1ATD, providing initial evidence that it is safe and effective, thereby expanding the donor pool.

PEDIATRIC TRANSPLANTATION (2023)

Article Pediatrics

Factors associated with thrombotic and hemorrhagic complications in pediatric liver transplant: A multi-center analysis from the Starzl Network for Excellence in Pediatric Transplantation

Kyle Soltys, Caroline Lemoine, Xingyu Zhang, Rukhmi Bhat, John Bucuvalas, Sara Rasmussen, Rene Romero, Irini Batsis, Blayne Sayed, John Tunno, Cassandra Confair, Sarah Vargas, Riccardo Superina, George Mazariegos

Summary: Thrombotic and hemorrhagic complications after pediatric liver transplant often affect the survival rate. Limited data exists regarding factors associated with these complications and utilization of anticoagulation. This study reviewed donor, recipient variables and outcomes from four centers and found that intraoperative hepatic artery thrombosis and recurrent postoperative thrombosis were associated with lower hepatic arterial flows and donor variant anatomy.

PEDIATRIC TRANSPLANTATION (2023)

Review Gastroenterology & Hepatology

Time since liver transplant and immunosuppression withdrawal outcomes: Systematic review and individual patient data meta-analysis

Christian Appenzeller-Herzog, Aurelie Rosat, Tim Mathes, Alberto Baroja-Mazo, Andrzej Chruscinski, Sandy Feng, Ignacio Herrero, Maria-Carlota Londono, George Mazariegos, Hidenori Ohe, Jose A. Pons, Alberto Sanchez-Fueyo, Kayo Waki, Julien Vionnet

Summary: Pre-withdrawal time has a significant impact on the success or failure of immunosuppression withdrawal in liver transplant recipients, according to a systematic review and meta-analysis.

LIVER INTERNATIONAL (2023)

Review Pediatrics

Balancing immunosuppression in pediatric liver transplantation: Playing the long game

Swati Antala, Joseph DiNorcia, John Bucuvalas

Summary: The goal in the care of pediatric liver transplant recipients is to optimize allograft and patient health. Precision medicine and individualized immunosuppression play a crucial role in balancing allograft health and medication side effects. Challenges include predicting allograft health and identifying operational tolerance. More research is needed to determine the clinical utility of innovative tools. Strategies to safely minimize immunosuppression and tailor it in a personalized way are possible, but immunosuppression-free transplant is not yet a reality. This review focuses on progress made in individualizing immunosuppression in pediatric liver transplantation for optimal outcomes.

PEDIATRIC TRANSPLANTATION (2023)

Article Pediatrics

Mapping children by ALT 4-5 years after liver transplant: Potential individual and population applications

Wesley Dixon, Emily R. Perito, John Bucuvalas, Sandy Feng

Summary: Although clinicians often measure ALT to assess allograft health in pediatric liver transplant recipients, decisions are usually made based on single values or qualitative trends rather than quantitative aggregation or synthesis. This study aims to develop and test a comprehensive ALT metric that can better guide clinical decision-making and population comparisons. The results show that the integrated ALT metric correlates with allograft function, survival, and drug concentration. Further investigation is needed to validate this novel ALT metric as a predictor of clinical outcomes and descriptor of populations.

PEDIATRIC TRANSPLANTATION (2023)

No Data Available